Pre-emptive immunotherapy with purified natural killer cells after haploidentical SCT: a prospective phase II study in two centers. (Q44667256)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22941380%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

title

Pre-emptive immunotherapy with purified natural killer cells after haploidentical SCT: a prospective phase II study in two centers (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22941380%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

1 reference

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22941380%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Jakob R. Passweg

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22941380%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

1

M Stern

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22941380%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

author name string

S Meyer-Monard

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22941380%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

R Esser

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22941380%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

T Tonn

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22941380%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

J Soerensen

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22941380%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

M Paulussen

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22941380%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

A Gratwohl

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22941380%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

T Klingebiel

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22941380%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

P Bader

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22941380%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

A Tichelli

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22941380%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

D Schwabe

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22941380%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

language of work or name

English

0 references

publication date

3 September 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22941380%20AND%20SRC:MED&resulttype=core&format=json

Bone Marrow Transplantation

12 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22941380%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

volume

48

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22941380%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22941380%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

page(s)

433-438

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22941380%20AND%20SRC:MED&resulttype=core&format=json

Haploidentical transplantation for leukemia.

12 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.162

Results and factors influencing outcome after fully haploidentical hematopoietic stem cell transplantation in children with very high-risk acute lymphoblastic leukemia: impact of center size: an analysis on behalf of the Acute Leukemia and Pediatric

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.162

Donor lymphocyte infusions in adult haploidentical transplant: a dose finding study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.162

Killer Ig–like receptor-mediated control of natural killer cell alloreactivity in haploidentical hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.162

Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.162

NK-cell reconstitution after haploidentical hematopoietic stem-cell transplantations: immaturity of NK cells and inhibitory effect of NKG2A override GvL effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.162

Natural-killer-cell-based treatment in haematopoietic stem-cell transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.162

Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.162

Minimal residual disease-directed therapy for childhood acute myeloid leukaemia: results of the AML02 multicentre trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.162

IL-2 activated NK cell immunotherapy of three children after haploidentical stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.162

Quantitative analysis of chimerism after allogeneic stem cell transplantation by PCR amplification of microsatellite markers and capillary electrophoresis with fluorescence detection: the Frankfurt experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.162

Ex vivo expansion of highly purified NK cells for immunotherapy after haploidentical stem cell transplantation in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.162

Cytofluorometric methods for assessing absolute numbers of cell subsets in blood. European Working Group on Clinical Cell Analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.162

A novel four-colour flow cytometric assay to determine natural killer cell or T-cell-mediated cellular cytotoxicity against leukaemic cells in peripheral or bone marrow specimens containing greater than 20% of normal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.162

Relevance of C1 and C2 epitopes for hemopoietic stem cell transplantation: role for sequential acquisition of HLA-C-specific inhibitory killer Ig-like receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.162

Good manufacturing practice-compliant cell sorting and large-scale expansion of single KIR-positive alloreactive human natural killer cells for multiple infusions to leukemia patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.162

Prospects for the use of NK cells in immunotherapy of human cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.162

NK cell-mediated targeting of human cancer and possibilities for new means of immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.162

The proinflammatory cytokines IL-2, IL-15 and IL-21 modulate the repertoire of mature human natural killer cell receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.162

IL-2 stimulated but not unstimulated NK cells induce selective disappearance of peripheral blood cells: concomitant results to a phase I/II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.162

IL-2-activated haploidentical NK cells restore NKG2D-mediated NK-cell cytotoxicity in neuroblastoma patients by scavenging of plasma MICA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.162

NKG2D ligand expression in AML increases in response to HDAC inhibitor valproic acid and contributes to allorecognition by NK-cell lines with single KIR-HLA class I specificities

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.162

Selective Expansion and Partial Activation of Human NK Cells and NK Receptor-Positive T Cells by IL-2 and IL-15

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.162

Successful transfer of alloreactive haploidentical KIR ligand-mismatched natural killer cells after infusion in elderly high risk acute myeloid leukemia patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.162

Treatment of high-risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.162

7 January 2021

Natural killer-cell KIR repertoire reconstitution after haploidentical SCT

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.162

7 January 2021

Purified donor NK-lymphocyte infusion to consolidate engraftment after haploidentical stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.162

7 January 2021

Clinical-grade purification of natural killer cells in haploidentical hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.162

7 January 2021

ISHAGE-based single-platform flowcytometric analysis for measurement of absolute viable T cells in fresh or cryopreserved products: CD34/CD133 selected or CD3/CD19 depleted stem cells, DLI and purified CD56+CD3− NK cells

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.162

7 January 2021

IL-2−driven Regulation of NK Cell Receptors With Regard to the Distribution of CD16+ and CD16− Subpopulations and In Vivo Influence After Haploidentical NK Cell Infusion

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.162

7 January 2021

European experience of bone-marrow transplantation for severe combined immunodeficiency

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.162

7 January 2021

Purification of human natural killer cells using a clinical-scale immunomagnetic method

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.162

7 January 2021

Interleukin-15 enhances cytotoxicity, receptor expression, and expansion of neonatal natural killer cells in long-term culture

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.162

7 January 2021

Identifiers

DOI

10.1038/BMT.2012.162

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22941380%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

1 reference